Phenergan, an antihistamine and antiemetic drug, has been prescribed for a number of years in the United States. In fact, it's become so popular "across the pond" in Europe that it's available over-the-counter in Switzerland and United Kingdom (among other countries).
Generally, Phenergan has been given to patients who are suffering from one or more of the following diseases or symptoms: hay fever, cough, morning sickness, and/or postnarcotic nausea. Phenergan has contraindications that include: intoxication with alcohol/depressants; coma; impaired liver function; urination difficulty (as a result of an enlarged prostate glad); and certain types of glaucoma.
Because Phenergan was widely used for so long, many felt at ease using and prescribing the drug. Though side effects such as drowsiness, dizziness, and fatigue were noted, they didn't seem to be different than other drugs used to treat the same illnesses. However, a 2005 warning issued by Phenergan's maker, Wyeth Pharmaceuticals, changed many people's comfort level with and about the medication.
In the 2005 letter issued to health care providers, Wyeth emphasized that a new contraindication had been added to Phenergan relating to the use of its product (either in tablet form or by suppositories) by toddlers age two and under.
As the letter unequivocally states: "Phenergan should not be used in pediatric patients less than two years of age because of the potential for fatal respiratory depression." (Wyeth Pharmaceuticals, 2005) This warning was a stinging reminder to the public that some medications that are thought to be "safe" may be anything but for certain members of the public (in this case, very young children.)
As a result of this public warning, many parents whose children had been given Phenergan became concerned, especially if they had noticed side effects as noted in the Wyeth letter. Though they might not have connected their children's symptoms to the use of Phenergan at the time, it soon became clear that their offspring had been dangerously exposed to a potentially fatal drug.
If you are one of those parents, grandparents, or physicians who used Phenergan to treat the symptoms of a young child who subsequently showed signs of respiratory distress, our law firm would like to speak with you. We are committed to ensuring the safety of the public, and are anticipating that many persons with negative Phenergan experiences will come forward to submit claims against Wyeth Pharmaceuticals.
Our phone number is toll free, and our representation will not cost you anything until restitution has been received.